Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 51, Issue 11, 2006, Pages 871-874

  Growdon, Whitfield B ^c   Wolfberg, Adam J ^c   Feltmate, Colleen M ^c   Goldstein, Donald P ^a   Genest, David R ^c   Chinchilla, Manuel E ^c   Berkowitz, Ross S ^b   Lieberman, Ellice S ^c  

^a Trophoblastic Tumor Registry   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c NONE

Author keywords

Gestational trophoblastic neoplasms; Human chorionic gonadotropin; Molar pregnancy

Indexed keywords

CONFERENCE PAPER; DIAGNOSTIC VALUE; DNA DETERMINATION; DOSE TIME EFFECT RELATION; FEMALE; HIGH RISK PATIENT; HORMONE DETERMINATION; HUMAN; HYDATIDIFORM MOLE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REMISSION; RISK ASSESSMENT; TROPHOBLASTIC TUMOR;

CHORIONIC GONADOTROPIN; FEMALE; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; HYDATIDIFORM MOLE; PREGNANCY; RETROSPECTIVE STUDIES; RISK; TUMOR MARKERS, BIOLOGICAL;

EID: 33751227855     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Berkowitz RS, Goldstein DP: Chorionic tumors. N Engl J Med 1996;335:1740-1748
2. Palmer JR: Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med 1994;39:155-162
3. Kohorn EI: Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia: A progress report. J Reprod Med 2002;47:445-450
4. Wolfberg AJ, Feltmate C, Goldstein DP, et al: Low risk of relapse after achieving undetectable hCG levels in women with complete molar pregnancy. Obstet Gynecol 2004;104:551-554
5. Goto S, Yamada A, Ishizuka T, et al: Development of postmolar trophoblastic disease alter partial molar pregnancy. Gynecol Oncol 1993;48:165-170
6. Bagshawe KD, Lawler SD, Paradinas FJ, et al: Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole. Lancet 1990;335:1074-1076
7. Berkowitz RS, Goldstein DP, Bernstein MR: Natural history of partial molar pregnancy. Obstet Gynecol 1985;66:677-681
8. Czernobilsky B, Barash A, Lancet M: Partial moles: A clinicopathologic study of 25 cases. Obstet Gynecol 1982;59:75-77
9. Szulman AE, Surti U: The clinicopathologic profile of the partial hydatidiform mole. Gynecol Oncol 1982;59:597-602
10. van Trommel NE, Sweep NC, Schiff CPT, et al: Diagnosis of hydatidiform mole and persistent trophoblastic disease: Diagnostic accuracy of total human chorionic gonadotropin (hCG) {alpha}- and {beta}-subunits, and their ratios. Bur J Endocrinol 2005;153:565-575
11. Smith EB, Szulman AR, Hinshaw W, et al: Human chorionic gonadotropin levels in complete and partial moles and in non-molar abortuses. Am J Obstet Gynecol 1984;149:129-132
12. Shigematsu T, Kamura T, Saito T, et al: Identification of persistent trophoblastic diseases based on a human chorionic gonadotropin regression curve by means of a stepwise piecewise linear regression analysis after the evacuation of uneventful moles. Gynecol Oncol 1998;71:376-380
13. Wolfberg AJ, Berkowitz RS, Goldstein DP, et al: Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy. Obstet Gynecol 2006;107:743
14. Wolfberg AJ, Berkowitz RS, Goldstein DP, et al: Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy. Obstet Gynecol 2005;106:548-552
15. Lavie I, Rao GG, Castrillon DH, et al: Duration of human-chorionic gonadotropin surveillance for partial hydatidiform moles. Am J Obstet Gynecol 2005;192:1362-1364
16. Wolfberg AJ, Growdon WB, Feltmate CM, et al: Low risk of relapse after achieving undetectable hCG levels in women with partial molar pregnancies. Obstet Gynecol 2006;108:393-396